Reaction
Agraphia reporting signals
As of the last recalculation, Agraphia appears in 593 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is NATALIZUMAB (PRR 56.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Natalizumab | 198 | 56.9 | 57.0 |
| Interferon Beta-1A | 185 | 48.4 | 48.4 |
| Diroximel Fumarate | 13 | 39.1 | 39.2 |
| Dimethyl Fumarate | 87 | 28.9 | 28.9 |
| Interferon Beta-1B | 8 | 14.8 | 14.8 |
| Peginterferon Beta-1A | 5 | 13.5 | 13.5 |
| Axicabtagene Ciloleucel | 3 | 10.7 | 10.7 |
| Drospirenone And Ethinyl Estradiol | 12 | 9.7 | 9.7 |